A Unique Case of Multisystem Langerhans Cell Histiocytosis Co-existing With Germline ANKRD26–Associated Non-Langerhans Cell Histiocytic Proliferation

ANKRD26-related thrombocytopenia is an inherited marrow disorder characterized by impaired megakaryocytic maturation and predisposition to myeloid neoplasia. Recent data have expanded its phenotypic spectrum to include non–Langerhans cell histiocytic proliferations; however, an association with Langerhans cell histiocytosis (LCH) has not been documented. We report a 7-month-old male infant with anemia, thrombocytopenia, hepatosplenomegaly, and diffuse seborrheic dermatitis–like skin lesions who was found to harbor a germline ANKRD26 mutation. Bone marrow examination demonstrated megakaryocytic dysplasia with paratrabecular clustering and an interstitial histiocytic proliferation composed of CD68-positive, S100/CD1a/Langerin-negative cells lacking BRAF V600E mutation, consistent with non–Langerhans cell histiocytosis. In contrast, skin biopsy revealed a morphologically and immunophenotypically distinct histiocytic infiltrate with grooved nuclei, expression of CD1a, Langerin, and S100, and presence of BRAF V600E mutation, confirming LCH. Whole-body imaging demonstrated multisystem involvement. The coexistence of 2 biologically distinct histiocytic proliferations in separate tissue compartments supports a germline–somatic interaction, wherein ANKRD26-associated myeloid dysregulation provides a permissive background for secondary oncogenic events. This case underscores the diagnostic importance of integrated morphologic, immunophenotypic, and tissue-specific molecular evaluation in pediatric histiocytic disorders.

Authors

Institutions

Publication Details

Journal
Pediatric and Developmental Pathology
Published
2026-11-19
DOI
https://doi.org/10.1177/10935266261506716
Primary Topic
Histiocytic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Unique Case of Multisystem Langerhans Cell Histiocytosis Co-existing With Germline ANKRD26–Associated Non-Langerhans Cell Histiocytic Proliferation

Ketki Kelkar, Rumma Manchanda, Kala Gnanasekaran Kiruthiga, Sarita Verma et al.
Pediatric and Developmental Pathology
Histiocytic Disorders and Treatments
article

A Unique Case of Multisystem Langerhans Cell Histiocytosis Co-existing With Germline ANKRD26–Associated Non-Langerhans Cell Histiocytic Proliferation

Ketki Kelkar, Rumma Manchanda, Kala Gnanasekaran Kiruthiga, Sarita Verma, Kannan Subramanian
article en

Abstract

ANKRD26-related thrombocytopenia is an inherited marrow disorder characterized by impaired megakaryocytic maturation and predisposition to myeloid neoplasia. Recent data have expanded its phenotypic spectrum to include non–Langerhans cell histiocytic proliferations; however, an association with Langerhans cell histiocytosis (LCH) has not been documented. We report a 7-month-old male infant with anemia, thrombocytopenia, hepatosplenomegaly, and diffuse seborrheic dermatitis–like skin lesions who was found to harbor a germline ANKRD26 mutation. Bone marrow examination demonstrated megakaryocytic dysplasia with paratrabecular clustering and an interstitial histiocytic proliferation composed of CD68-positive, S100/CD1a/Langerin-negative cells lacking BRAF V600E mutation, consistent with non–Langerhans cell histiocytosis. In contrast, skin biopsy revealed a morphologically and immunophenotypically distinct histiocytic infiltrate with grooved nuclei, expression of CD1a, Langerin, and S100, and presence of BRAF V600E mutation, confirming LCH. Whole-body imaging demonstrated multisystem involvement. The coexistence of 2 biologically distinct histiocytic proliferations in separate tissue compartments supports a germline–somatic interaction, wherein ANKRD26-associated myeloid dysregulation provides a permissive background for secondary oncogenic events. This case underscores the diagnostic importance of integrated morphologic, immunophenotypic, and tissue-specific molecular evaluation in pediatric histiocytic disorders.

Pediatric and Developmental Pathology
King Edward Memorial Hospital Research Centre (IN)
Histiocytic Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon